SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001358403-20-000026
Filing Date
2020-11-05
Accepted
2020-11-05 16:30:25
Documents
16
Period of Report
2020-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blcm-20201105.htm   iXBRL 8-K 36440
2 EX-99.1 a2020q3exh991earningsr.htm EX-99.1 83772
8 image1.jpg GRAPHIC 34612
  Complete submission text file 0001358403-20-000026.txt   317842

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20201105.xsd EX-101.SCH 2423
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20201105_cal.xml EX-101.CAL 710
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20201105_def.xml EX-101.DEF 1643
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20201105_lab.xml EX-101.LAB 24030
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20201105_pre.xml EX-101.PRE 12661
9 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20201105_htm.xml XML 10722
Mailing Address 2710 REED ROAD SUITE 160 HOUSTON TX 77051
Business Address 2710 REED ROAD SUITE 160 HOUSTON TX 77051 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 201290957
SIC: 2834 Pharmaceutical Preparations